Evaluation of radioiodinated medium chain fatty acids as new diagnostic agents for the determination of hepatic viability

European Journal of Nuclear Medicine

Volumn 26, Issue 12, 1999, Pages 1597-1605

  Yamamura, Norio ^a   Magata, Yasuhiro ^a   Konishi, Junji ^a   Saji, Hideo ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Energy metabolism; Hepatic viability; Liver; Medium chain fatty acids; Single photon emission tomography

Indexed keywords

4 IODOPHENYLENANTHIC ACID; 4 IODOPHENYLVALERIC ACID; DIAGNOSTIC AGENT; MEDIUM CHAIN FATTY ACID; OMEGA 3 FATTY ACID; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL VIABILITY; CHEMICAL STRUCTURE; CONTROLLED STUDY; ENERGY METABOLISM; FATTY ACID OXIDATION; LIVER CELL; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; RADIOIODINATION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANIMALS; CELL SURVIVAL; EVALUATION STUDIES; FATTY ACIDS; IODINE RADIOISOTOPES; LIVER; MALE; MICE; RADIOPHARMACEUTICALS; RATS; RATS, WISTAR; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0033452286     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050500     Document Type: Article

References (23)

1. 1. Liu W, Schob O, Pugmire JE, Jackson D, Zucker KA, Fry DE, Glew RH. Glycohydrolases as markers of hepatic ischemia-reperfusion injury and recovery. Hepatology 1996; 24: 157-162.
2. 2. Martin DB. Metabolism and energy mechanisms. In Frohlich ED, ed. Pathophysiology. Philadelphia: Lippincott; 1976: 365-383.
3. 3. Zakim D. Metabolism of glucose and fatty acids by the liver. In: Zakim D, Boyer TD, eds. Hepatology. Philadelphia: Saunders; 1982: 76-109.
4. 4. Kornberg A, Pricer WEJ. Enzymatic esterification of α-glycerophosphate by long chain fatty acids. J Biol Chem 1953; 204: 345-357.
5. 5. Lossow WJ, Chaikoff IL. Carbohydrate sparing of fatty acid oxidation. I. The relation of fatty acid chain length to the degree of sparing. II. The metabolism by which carbohydrate spares the oxidation of palmitic acid. Arch Biochem Biophys 1955; 57: 23-40.
6. 6. Fraitz IB. Factors influencing the rates of long-chain fatty acid oxidation and synthesis in mammalian systems. Physiol Rev 1961; 41: 51-129.
7. 11C]octanoate as a new radiopharmaceutical for assessing liver function using positron emission tomography. Nucl Med Biol 1998; 25: 467-472.
8. 123/131I-phenyl)-pentadecanoic acid (pPPA) in animals and man. J Nucl Med 1990; 31: 1608-1616.
9. 9. Newton BT. Iodine-containing organic carbonates as investigative radiopaque compounds. J Med Chem 1976; 19: 1362-1366.
10. 64Cu labelling of fatty acid analogs containing dithiosemicarbazone chelate. Int J Rad Appl Instrum [A] 1989; 40: 745-749.
11. 131I-labelled N-isopropyl-p-iodoamphetamine. Eur J Nucl Med 1982; 7: 280-281.
12. 12. Hjelle JJ, Grubbs JH, Beer DG, Petersen DR. Time course of the carbon tetrachloride-induced decrease in mitochondrial aldehyde dehydrogenase activity. Toxicol Appl Pharmacol 1983; 67: 159-165.
13. 13. Folch J, Less M, Sloane-Stanley GH. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957; 226: 497-509.
14. 14. Yamaoka K, Tanigawara Y, Nakagawa T, Uno T. A pharmacokinetic analysis program (MULTI) for microcomputer. J Pharmacobiodyn 1981; 4: 879-885.
15. 15. Sellevold OFM, Jynge P, Aarstad K. High performance liquid chromatography: a rapid isocratic method for determination of creatine compounds and adenine nucleotides in myocardial tissue. J Mol Cell Cardiol 1986; 18: 517-527.
16. 16. Raaka BM, Lowenstein JM. Inhibition of fatty acid oxidation by 2-bromooctanoate. Including effects of bromooctanoate on ketogenesis and gluconeogenesis. J Biol Chem 1979; 254: 3303-3310.
17. 17. Raaka BM, Lowenstein JM. Inhibition of fatty acid oxidation by 2-bromooctanoate. Evidence for the enzymatic formation of 2-bromo-3-ketooctanoyl coenzyme A and the inhibition of 3-ketothiolase. J Biol Chem 1979; 254: 6755-6762.
18. 11C]octanoate in rats: pharmacokinetic basis for its application as a radiopharmaceutical for studying brain fatty acid metabolism. Ann Nucl Med 1995; 9: 137-142.
19. 19. Goodman MM, Kirsch G, Knapp FFJ. Synthesis and evaluation of radioiodinated terminal p-iodophenyl-substituted alpha-and beta-methyl-branched fatty acids. J Med Chem 1984; 27: 390-397.
20. 20. Kamiike W, Burdelski M, Steinhoff G, Ringe B, Lauchart W, Pichlmayr R. Adenine nucleotide metabolism and its relation to organ viability in human liver transplantation. Transplantation 1988; 45: 138-143.
21. 21. Lanir A, Jenkins RL, Caldwell C, Lee RG, Khettry U, Clouse ME. Hepatic transplantation survival: correlation with adenine nucleotide level in donor liver. Hepatology 1988; 8: 471-475.
22. 22. Schelbert HR, Henze E, Schon HR, Keen R, Hansen H, Selin C, Huang SC, Barrio JR, Phelps ME. C-11 palmitate for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron computed tomography. III. In vivo demonstration of the effects of substrate availability on myocardial metabolism. Am Heart J 1983; 105: 492-504.
23. 23. Schelbert HR, Henze E, Keen R, Schon HR, Hansen H, Selin C, Huang SC, Barrio JR, Phelps ME. C-11 palmitate for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron-computed tomography. IV. In vivo evaluation of acute demand-induced ischemia in dogs. Am Heart J 1983; 106: 736-750.